Skip to main content
Caplight Logo









Seroba Life Sciences

Seroba Life Sciences

Overview

Seroba Life Sciences is a European venture capital firm focused on investing in innovative biotech and medtech companies that address unmet medical needs.

Year Founded

2002

Portfolio Companies

17

Investments

Seroba Life Sciences investments
CompanyDateStageLead
Quanta Dialysis TechnologiesJun 2021Series DCo-investor
STORM TherapeuticsDec 2022Series BCo-investor
DeciphexJan 2025Series CCo-investor
Quanta U.S., Inc.-Series A ExtensionCo-investor
Sibylla BiotechOct 2022Series ACo-investor
Book a demo to see all 17 portfolio companies

For institutional investors. Book with your work email.

Key People

Jeanne Bolger

Venture Partner

Alan O'Connell

Partner

Bruno Montanari

Partner

Catello Somma

Partner

Daniel O'Mahony

Partner

Jennifer McMahon

Partner

Maud Lazare

Partner, Head of Investor Relations

Book a demo to see all key people

For institutional investors. Book with your work email.

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Portfolio analytics

Caplight clients see full sector, stage and valuation breakdowns for this investor.

Book a demo to see full analytics

For institutional investors. Book with your work email.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Portfolio analytics

Caplight clients see yearly investment pace and funding raised over time.

Book a demo to see full analytics

For institutional investors. Book with your work email.

FAQ

Where is Seroba Life Sciences based?

Seroba Life Sciences is headquartered in Dublin, Ireland.

When was Seroba Life Sciences founded?

Seroba Life Sciences was founded in 2002.

How many portfolio companies does Seroba Life Sciences have?

Seroba Life Sciences has 17 portfolio companies in Caplight's dataset.

What are some companies in Seroba Life Sciences's portfolio?

Portfolio companies visible on Caplight include Quanta Dialysis Technologies, STORM Therapeutics, Deciphex, Quanta U.S., Inc., Sibylla Biotech.

What was Seroba Life Sciences's most recent investment shown here?

Seroba Life Sciences's most recent investment in this portfolio sample was in Deciphex in 2025.

What sectors does Seroba Life Sciences focus on?

Seroba Life Sciences focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Enterprise Software, Mobility, Transportation & Logistics, AI, Data & Cloud Infrastructure.

What company stages does Seroba Life Sciences focus on?

Seroba Life Sciences typically invests at the Mid stage.

What is Seroba Life Sciences's AUM?

Seroba Life Sciences's assets under management are estimated between $100.0M and $250.0M.

Firmographic Details

HeadquartersDublin
Year Founded2002

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?